Welcome!

News Feed Item

Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018

DUBLIN, April 16, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/btrshd/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are objectively measured as an indicator of typical biological processes, pathogenic processes, or pharmacologic response to a therapeutic intrusion. Major application areas of biomarkers are early disease diagnosis and prevention, drug target recognition, and drug discovery and development. The global market showcases high growth potential in the near future. This market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.

The global market has been segmented into biomarker discovery technologies, biomarker services, applications, and disease indications. The biomarker discovery technologies are classified as omics technology, imaging technology, and bioinformatics. Omics technology, which includes proteomics, genomics, transcriptomics, and metabolomics, accounts for the largest share of the biomarker discovery technology market. The biomarkers services market is classified into sample preparation, assay development, and biomarker validation and testing services. Biomarker applications market has been segmented as drug discovery and development, molecular diagnostics, and personalized medicine. Based on type of diseases, the biomarker disease indication market has been classified as oncology, cardiology, neurology, and other diseases (HIV, renal disorders, diabetes, arthritis, and tuberculosis).

Globally, the biomarkers market is witnessing a transformation and is expected to grow at a high growth rate in the coming years. The growth in the market will be primarily driven by advancements in discovery technologies, government initiatives and grants for biomarker research activities, and rising demand for personalized medicine. The incidence and prevalence of chronic diseases such as cancer, cardiac diseases, and diabetes is increasing globally and hence, it is crucial to develop new preventive and diagnostics treatments. Since, biomarkers play a significant role in development of preventive and diagnostic tests and drugs, the demand of biomarkers is expected to increase rapidly.

Over the past few years, the biomarkers industry has been witnessing increasing number of contracts and partnership agreements among market players for the development of novel biomarkers. Major research on biomarkers is taking place in the field of oncology. Recent developments of companies such as Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Roche Diagnostics (Switzerland), Hologic, Inc. (U.S.), and Johnson & Johnson (U.S.) have exhibited inclination towards agreements and partnerships, in accordance to their key strategy to expand their market share and geographical presence.


Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Biomarkers Market, By Discovery Technologies

5 Services Market Of Biomarkers

6 Biomarkers Application Market

7 Biomarkers Indication Market

8 Geographical Analysis

9 Competitive Landscape

10 Company Profiles


Companies Mentioned: 

  • Abbott Laboratories
  • Abcodia Ltd
  • Affymetrix Inc
  • Agilent Technologies Inc
  • Amgen Inc
  • Astrazeneca Plc
  • Augurex Life Sciences Corp
  • Aushon Biosystems Inc
  • BGI
  • Bayer Ag
  • Beckman Coulter Inc
  • Biocrates Life Sciences AG
  • Biomarkers Strategies
  • Biosystems International
  • Bristol-Myers Squibb
  • Caprion Proteomics Inc
  • Crescendo Bioscience
  • Eisai Co Ltd
  • Epiontis GMBH
  • Epistem Holdings PLC
  • Eurogentec SA
  • Evotec AG
  • Glaxosmithkline PLC
  • Ipsen
  • Johnson & Johnson
  • Merck & Co
  • Micromedic Technologies Ltd
  • Myriad Genetics Inc
  • Nextgen Sciences Inc
  • Novartis International AG
  • Ocimum Biosolutions Ltd
  • Pacific Biomarkers Inc
  • Pfizer Inc
  • Pronota NV
  • Proteome Sciences Plc
  • Qiagen Nv
  • Quintiles Transnational Corporation
  • Roche Diagnostics Limited
  • Sanofi-Aventis
  • Siemens Healthcare
  • Trans-Hit Biomarkers Inc
  • Vermillion Inc



For more information visit http://www.researchandmarkets.com/research/btrshd/biomarkers_market


Media Contact: Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today the Enterprise IoT Bootcamp, being held November 1-2, 2016, in conjunction with 19th Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA. Combined with real-world scenarios and use cases, the Enterprise IoT Bootcamp is not just based on presentations but with hands-on demos and detailed walkthroughs. We will introduce you to a variety of real world use cases prototyped using Arduino, Raspberry Pi, BeagleBone, Spark, and Intel Edison. Y...
Complete Internet of Things (IoT) embedded device security is not just about the device but involves the entire product’s identity, data and control integrity, and services traversing the cloud. A device can no longer be looked at as an island; it is a part of a system. In fact, given the cross-domain interactions enabled by IoT it could be a part of many systems. Also, depending on where the device is deployed, for example, in the office building versus a factory floor or oil field, security ha...
Is your aging software platform suffering from technical debt while the market changes and demands new solutions at a faster clip? It’s a bold move, but you might consider walking away from your core platform and starting fresh. ReadyTalk did exactly that. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, will discuss why and how ReadyTalk diverted from healthy revenue and over a decade of audio conferencing product development to start an innovati...
Fifty billion connected devices and still no winning protocols standards. HTTP, WebSockets, MQTT, and CoAP seem to be leading in the IoT protocol race at the moment but many more protocols are getting introduced on a regular basis. Each protocol has its pros and cons depending on the nature of the communications. Does there really need to be only one protocol to rule them all? Of course not. In his session at @ThingsExpo, Chris Matthieu, co-founder and CTO of Octoblu, walk you through how Oct...
The Jevons Paradox suggests that when technological advances increase efficiency of a resource, it results in an overall increase in consumption. Writing on the increased use of coal as a result of technological improvements, 19th-century economist William Stanley Jevons found that these improvements led to the development of new ways to utilize coal. In his session at 19th Cloud Expo, Mark Thiele, Chief Strategy Officer for Apcera, will compare the Jevons Paradox to modern-day enterprise IT, e...
SYS-CON Events announced today that Bsquare has been named “Silver Sponsor” of SYS-CON's @ThingsExpo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. For more than two decades, Bsquare has helped its customers extract business value from a broad array of physical assets by making them intelligent, connecting them, and using the data they generate to optimize business processes.
Whether they’re located in a public, private, or hybrid cloud environment, cloud technologies are constantly evolving. While the innovation is exciting, the end mission of delivering business value and rapidly producing incremental product features is paramount. In his session at @DevOpsSummit at 19th Cloud Expo, Kiran Chitturi, CTO Architect at Sungard AS, will discuss DevOps culture, its evolution of frameworks and technologies, and how it is achieving maturity. He will also cover various st...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
There are several IoTs: the Industrial Internet, Consumer Wearables, Wearables and Healthcare, Supply Chains, and the movement toward Smart Grids, Cities, Regions, and Nations. There are competing communications standards every step of the way, a bewildering array of sensors and devices, and an entire world of competing data analytics platforms. To some this appears to be chaos. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, Bradley Holt, Developer Advocate a...
SYS-CON Events announced today that Niagara Networks will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
SYS-CON Events announced today that Secure Channels will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. The bedrock of Secure Channels Technology is a uniquely modified and enhanced process based on superencipherment. Superencipherment is the process of encrypting an already encrypted message one or more times, either using the same or a different algorithm.
If you’re responsible for an application that depends on the data or functionality of various IoT endpoints – either sensors or devices – your brand reputation depends on the security, reliability, and compliance of its many integrated parts. If your application fails to deliver the expected business results, your customers and partners won't care if that failure stems from the code you developed or from a component that you integrated. What can you do to ensure that the endpoints work as expect...
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, provided tips on how to be successful in large scale machine learning...
If you had a chance to enter on the ground level of the largest e-commerce market in the world – would you? China is the world’s most populated country with the second largest economy and the world’s fastest growing market. It is estimated that by 2018 the Chinese market will be reaching over $30 billion in gaming revenue alone. Admittedly for a foreign company, doing business in China can be challenging. Often changing laws, administrative regulations and the often inscrutable Chinese Interne...
In his general session at 18th Cloud Expo, Lee Atchison, Principal Cloud Architect and Advocate at New Relic, discussed cloud as a ‘better data center’ and how it adds new capacity (faster) and improves application availability (redundancy). The cloud is a ‘Dynamic Tool for Dynamic Apps’ and resource allocation is an integral part of your application architecture, so use only the resources you need and allocate /de-allocate resources on the fly.